| Ytd | -4.16% | |
| 1y | -24.73% |
| Open | 0.50 | Prev Close | 0.46 | Low | 0.47 | High | 0.50 | Mkt Cap | 52.19M |
| Vol | 170.91K | Avg Vol | 86.60K | EPS | -0.29 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | 0.06 | Inst. Own | 1.42% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.57 | 200-d Avg | 0.55 | 1yr Est | 0.00 |
PAVS stock rose 65.6% in pre-market trading after ending sales agreement with A.G.P/Alliance Global
Faraday Future Intelligent Electric shares up 54.8% in pre-market trading after SEC investigation en
Dow down 800 points, S&P 500 and NASDAQ also fall. Energy sector rises, healthcare dips. BJ repo
US stocks down, Dow falls 300 points. Dow traded at 48,411.44, NASDAQ at 22,741.80, S&P 500 at 6
Shares of Veeva Systems Inc (NYSE: VEEV) gained 11.3% in pre-market trading on upbeat Q4 results and
Impact Biomedical shares jumped 86% after hours following amended merger terms with Dr Ashleys Bio L
On July 21, 2025, Impact BioMedical Inc. (the "Company" or "Borrower") entered into